Sarepta’s stock sank after studies of Duchenne muscular dystrophy treatments failed their primary endpoints.

Seeking Alpha’s Disclaimer: The earnings call insights are compilations of earnings call transcripts and other…

The software company is boosting its outlook, and its CEO is cheering gains for retail…

Bitcoin has broken below an important technical level, which could signal further downside for the…

The U.S. coffee-shop chain is forming a joint venture with Boyu Capital, with Boyu holding…

The meme stock said that it needs more time to quantify a previously disclosed impairment…